Detail page

Knowledge Web

Person

Jürgen C. Becker (1964-)

Arzt

Name	Jürgen C. Becker
Time	1964- (Date of birth and death)
Place	Deutschland
Gender	männlich
Academic degree	Dr. med. Dr.med.habil PhD
Profession	Arzt (characteristic profession) Hautarzt
Variant	Jürgen Christian Becker J. C. Becker
Related	Klinik und Poliklinik für Haut- und Geschlechtskrankheiten (Würzburg) Universitätsklinik für Dermatologie und Venerologie (Graz) (-2014) Universitätsklinikum Essen (2014-) Westdeutsches Tumorzentrum (2014-)
Topic	Personen zu Medizin, Tiermedizin
Further information	Leiter der Abteilung „Translationale Onkologie mit Schwerpunkt Hautkrebsforschung“ in Assoziation mit der Klinik für Dermatologie am Universitätsklinikum Essen
Source	Homepage: https://www.uk-essen.de/aktuelles/detailanzeige0/?tx_ttnews%5Btt_news%5D=1706&cHash=2337a0374f193507d4efb4f9bab964d9; https://www.aerzteblatt.de/archiv/159603/Aufgaben-und-Aemter (Stand: 21.10.2020) DNB
Record type	Person
GND-Identifier	129853437
Record ID	129853437
Involved in show all High-resolution spatial transcriptomics uncover epidermal-dermal divergences in Merkel cell carcinoma: spatial context reshapes the gene expression landscape Update Merkelzellkarzinom : Aktuelles zu Immunbiologie, Epidemiologie und Immuntherapie Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma : a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases Outcome of systemic therapy in patients with advanced rare skin cancers: a retrospective multicenter DeCOG study of 209 patients S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2 : epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG Update Merkel-Zell-Karzinom Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates Correction: Mesenchymal–epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression A prospective study investigating immune checkpoint molecule and CD39 expression on peripheral blood cells for the prognostication of COVID-19 severity and mortality Current progress in vaccines against Merkel cell carcinoma : a narrative review and update Introducing MCC-PS : a novel prognostic score for Merkel cell carcinoma The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results Mesenchymal–epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression 1168P Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined [Abstract] Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM German S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" – long version of the update 2023 Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG Model for end-stage liver disease correlates with disease relapse and death of patients with Merkel cell carcinoma Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care The antineoplastic effect of dimethyl fumarate on virus-negative Merkel cell carcinoma cell lines : preliminary results Merkel cell carcinoma of the anorectum: a case report and review of the literature Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization Characterization of a novel microfluidic platform for the isolation of rare single cells to enable CTC analysis from head and neck squamous cell carcinoma patients Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma Artesunate affects T antigen expression and survival of virus-positive Merkel cell carcinoma Comparison of mutation profiles in primary melanomas and corresponding nodal naevi using next‐generation sequencing Highly expressed miR-375 is not an intracellular oncogene in Merkel cell polyomavirus-associated Merkel cell carcinoma Serum neuron‐specific enolase independently predicts outcomes of patients with Merkel cell carcinoma Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever : case report and genomic characterization Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study Merkel-Zell-Karzinom Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma Expression of Hedgehog signalling molecules in microcystic adnexal carcinoma Expression of mismatch repair proteins in Merkel cell carcinoma Expression of potential targets for cell-based therapies on melanoma cells Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma : a retrospective multicenter DeCOG study Waiving subsequent complete lymph node dissection in melanoma patients with positive sentinel lymph node does not result in worse outcome on 20-year analysis Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53 BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes Retrospective Multicenter Analysis of the Outcome of a Re-Induction with Immune Checkpoint Inhibitors in Advanced Merkel Cell Carcinoma UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines Altered hydroxymethylation in cutaneous squamous cell carcinoma and keratoacanthoma Cancer and immune checkpoint inhibitor treatment in the era of SARS-CoV-2 infection Decline of programmed death-1-positive circulating T regulatory cells predicts more favourable clinical outcome of patients with melanoma under immune checkpoint blockade Does very early timing of lymph node surgery after resection of the primary tumour improve the clinical outcome of patients with melanoma? Expression of Lefty predicts Merkel cell carcinoma-specific death Retrospective multicenter analysis of the outcome of a re-induction with immune checkpoint inhibitors in advanced Merkel cell carcinoma S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC), short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Jürgen C. Becker (1964-)

High-resolution spatial transcriptomics uncover epidermal-dermal divergences in Merkel cell carcinoma: spatial context reshapes the gene expression landscape

Update Merkelzellkarzinom : Aktuelles zu Immunbiologie, Epidemiologie und Immuntherapie

Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma : a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis

Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases

Outcome of systemic therapy in patients with advanced rare skin cancers: a retrospective multicenter DeCOG study of 209 patients

S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2 : epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention

Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG

Update Merkel-Zell-Karzinom

Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates

Correction: Mesenchymal–epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression

A prospective study investigating immune checkpoint molecule and CD39 expression on peripheral blood cells for the prognostication of COVID-19 severity and mortality

Current progress in vaccines against Merkel cell carcinoma : a narrative review and update

Introducing MCC-PS : a novel prognostic score for Merkel cell carcinoma

The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations

The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results

Mesenchymal–epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression

The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression

1168P Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined [Abstract]

Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM

German S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" – long version of the update 2023

Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

Model for end-stage liver disease correlates with disease relapse and death of patients with Merkel cell carcinoma

Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics

S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention

S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“: update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care

The antineoplastic effect of dimethyl fumarate on virus-negative Merkel cell carcinoma cell lines : preliminary results

Merkel cell carcinoma of the anorectum: a case report and review of the literature

Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization

Characterization of a novel microfluidic platform for the isolation of rare single cells to enable CTC analysis from head and neck squamous cell carcinoma patients

Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma

Artesunate affects T antigen expression and survival of virus-positive Merkel cell carcinoma

Comparison of mutation profiles in primary melanomas and corresponding nodal naevi using next‐generation sequencing

Highly expressed miR-375 is not an intracellular oncogene in Merkel cell polyomavirus-associated Merkel cell carcinoma

Serum neuron‐specific enolase independently predicts outcomes of patients with Merkel cell carcinoma

Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever : case report and genomic characterization

Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study

Merkel-Zell-Karzinom

Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma

Digital quantification of tumor PD-L1 predicts outcome of PD-1-based immune checkpoint therapy in metastatic melanoma

Expression of Hedgehog signalling molecules in microcystic adnexal carcinoma

Expression of mismatch repair proteins in Merkel cell carcinoma

Expression of potential targets for cell-based therapies on melanoma cells

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis

Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma : a retrospective multicenter DeCOG study

Waiving subsequent complete lymph node dissection in melanoma patients with positive sentinel lymph node does not result in worse outcome on 20-year analysis

Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes

Retrospective Multicenter Analysis of the Outcome of a Re-Induction with Immune Checkpoint Inhibitors in Advanced Merkel Cell Carcinoma

UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines

Altered hydroxymethylation in cutaneous squamous cell carcinoma and keratoacanthoma

Cancer and immune checkpoint inhibitor treatment in the era of SARS-CoV-2 infection

Decline of programmed death-1-positive circulating T regulatory cells predicts more favourable clinical outcome of patients with melanoma under immune checkpoint blockade

Does very early timing of lymph node surgery after resection of the primary tumour improve the clinical outcome of patients with melanoma?

Expression of Lefty predicts Merkel cell carcinoma-specific death

Retrospective multicenter analysis of the outcome of a re-induction with immune checkpoint inhibitors in advanced Merkel cell carcinoma

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease

S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC), short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease